Edmund Harrigan's Net Worth

Edmund Harrigan's net worth is estimated to be at least $2,811,390.00 as of 11/23/2024. CoreStreet's estimation of Edmund Harrigan's net worth is based on their sale of stock and current holding of stock.

Edmund Harrigan is Director at PhaseBio Pharmaceuticals Inc. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,000 units of PHAS stock on 12/03/2020. Their biggest sale was on 06/12/2020 when they sold 30,000 units of Karuna Therapeutics Inc stock for $2,753,700.00. They typically trade 1 times per year.

Total value of insider buys:
  • $57,690.00
Total value of insider sells:
  • $2,753,700.00
Most recent insider trade:
  • Dec. 3, 2020

Edmund Harrigan's Insider Trading History

PhaseBio Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Dec. 3, 2020
Director6,000$4.12Buy$24,720.00
Karuna Therapeutics IncTitleAmountPriceTypeTotal Value
June 12, 2020
Director30,000$91.79Sell$2,753,700.00
ACADIA Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Aug. 16, 2016
Director1,000$32.97Buy$32,970.00